Association of enterolactone with blood pressure and hypertension risk in NHANES.

The gut microbiome may affect overall cardiometabolic health. Enterolactone is an enterolignan reflective of dietary lignan intake and gut microbiota composition and diversity that can be measured in the urine. The purpose of this study was to examine the association between urinary enterolactone co...

Full description

Saved in:
Bibliographic Details
Main Authors: Cynthia M Weiner, Shannon E Khan, Caleb Leong, Sushant M Ranadive, Sara C Campbell, Jeffrey T Howard, Kevin S Heffernan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302254&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555367779106816
author Cynthia M Weiner
Shannon E Khan
Caleb Leong
Sushant M Ranadive
Sara C Campbell
Jeffrey T Howard
Kevin S Heffernan
author_facet Cynthia M Weiner
Shannon E Khan
Caleb Leong
Sushant M Ranadive
Sara C Campbell
Jeffrey T Howard
Kevin S Heffernan
author_sort Cynthia M Weiner
collection DOAJ
description The gut microbiome may affect overall cardiometabolic health. Enterolactone is an enterolignan reflective of dietary lignan intake and gut microbiota composition and diversity that can be measured in the urine. The purpose of this study was to examine the association between urinary enterolactone concentration as a reflection of gut health and blood pressure/risk of hypertension in a large representative sample from the US population. This analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) collected from January 1999 through December 2010. Variables of interest included participant characteristics (including demographic, anthropometric and social/environmental factors), resting blood pressure and hypertension history, and urinary enterolactone concentration. 10,637 participants (45 years (SE = 0.3), 51.7% (SE = 0.6%) were female) were included in analyses. In multivariable models adjusted for demographic, socioeconomic and behavioral/environmental covariates, each one-unit change in log-transformed increase in enterolactone was associated with a 0.738 point (95% CI: -0.946, -0.529; p<0.001) decrease in systolic blood pressure and a 0.407 point (95% CI: -0.575, -0.239; p<0.001) decrease in diastolic blood pressure. Moreover, in fully adjusted models, each one-unit change in log-transformed enterolactone was associated with 8.2% lower odds of hypertension (OR = 0.918; 95% CI: 0.892, 0.944; p<0.001). Urinary enterolactone, an indicator of gut microbiome health, is inversely associated with blood pressure and hypertension risk in a nationally representative sample of U.S. adults.
format Article
id doaj-art-1ce6f88ec1c14b52a22c992c540fa589
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-1ce6f88ec1c14b52a22c992c540fa5892025-01-08T05:33:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01195e030225410.1371/journal.pone.0302254Association of enterolactone with blood pressure and hypertension risk in NHANES.Cynthia M WeinerShannon E KhanCaleb LeongSushant M RanadiveSara C CampbellJeffrey T HowardKevin S HeffernanThe gut microbiome may affect overall cardiometabolic health. Enterolactone is an enterolignan reflective of dietary lignan intake and gut microbiota composition and diversity that can be measured in the urine. The purpose of this study was to examine the association between urinary enterolactone concentration as a reflection of gut health and blood pressure/risk of hypertension in a large representative sample from the US population. This analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) collected from January 1999 through December 2010. Variables of interest included participant characteristics (including demographic, anthropometric and social/environmental factors), resting blood pressure and hypertension history, and urinary enterolactone concentration. 10,637 participants (45 years (SE = 0.3), 51.7% (SE = 0.6%) were female) were included in analyses. In multivariable models adjusted for demographic, socioeconomic and behavioral/environmental covariates, each one-unit change in log-transformed increase in enterolactone was associated with a 0.738 point (95% CI: -0.946, -0.529; p<0.001) decrease in systolic blood pressure and a 0.407 point (95% CI: -0.575, -0.239; p<0.001) decrease in diastolic blood pressure. Moreover, in fully adjusted models, each one-unit change in log-transformed enterolactone was associated with 8.2% lower odds of hypertension (OR = 0.918; 95% CI: 0.892, 0.944; p<0.001). Urinary enterolactone, an indicator of gut microbiome health, is inversely associated with blood pressure and hypertension risk in a nationally representative sample of U.S. adults.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302254&type=printable
spellingShingle Cynthia M Weiner
Shannon E Khan
Caleb Leong
Sushant M Ranadive
Sara C Campbell
Jeffrey T Howard
Kevin S Heffernan
Association of enterolactone with blood pressure and hypertension risk in NHANES.
PLoS ONE
title Association of enterolactone with blood pressure and hypertension risk in NHANES.
title_full Association of enterolactone with blood pressure and hypertension risk in NHANES.
title_fullStr Association of enterolactone with blood pressure and hypertension risk in NHANES.
title_full_unstemmed Association of enterolactone with blood pressure and hypertension risk in NHANES.
title_short Association of enterolactone with blood pressure and hypertension risk in NHANES.
title_sort association of enterolactone with blood pressure and hypertension risk in nhanes
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0302254&type=printable
work_keys_str_mv AT cynthiamweiner associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT shannonekhan associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT calebleong associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT sushantmranadive associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT saraccampbell associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT jeffreythoward associationofenterolactonewithbloodpressureandhypertensionriskinnhanes
AT kevinsheffernan associationofenterolactonewithbloodpressureandhypertensionriskinnhanes